Trial intelligence / Profile preview

Ketorolac for Postoperative Pain in Pediatric Circumcision

NCT02973958Phase 1Completed

Sponsor
Alberta Children's Hospital
Start
Feb 2017
Primary completion
Jun 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, single-blind trial of ketorolac in postoperative pain (2 arms), sponsored by Alberta Children's Hospital. Primary endpoint: Post-operative pain at 24 hours. Started Feb 2017; status: completed.

02

Drugs

ketorolac
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02973958.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02973958.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call